These insights substantially contribute to understanding the underlying mechanisms triggering atherosclerotic lesions in response to blood flow, offering promising avenues for targeted interventions focused on MAPK6 to prevent and treat atherosclerosis. This evidence concerns the gene MAPK6 and atherosclerosis.